| # | Drug | Count |
|---|---|---|
| 0 | CARBIDOPA AND LEVODOPA | 3 |
| 1 | AMBRISENTAN | 2 |
| 2 | DICLOFENAC SODIUM | 2 |
| 3 | FOSCARBIDOPA/FOSLEVODOPA | 2 |
| 4 | PANTOPRAZOLE | 2 |
| 5 | PREDNISONE | 2 |
| 6 | QUETIAPINE | 2 |
| 7 | SELEXIPAG | 2 |
| 8 | TADALAFIL | 2 |
| 9 | ACETAMINOPHEN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OMAVELOXOLONE | 1 | 0.0006 |
| 1 | FOSCARBIDOPA/FOSLEVODOPA | 2 | 0.0002 |
| 2 | MIDODRINE HYDROCHLORIDE | 1 | 0.0002 |
| 3 | TROFINETIDE | 1 | 0.0001 |
| 4 | RASAGILINE MESYLATE | 1 | 0.0001 |
| 5 | SELEXIPAG | 2 | 0.0001 |
| 6 | REMDESIVIR | 1 | 0.0001 |
| 7 | ROPINIROLE | 1 | 0.0001 |
| 8 | CARBIDOPA AND LEVODOPA | 3 | 0.0001 |
| 9 | VALGANCICLOVIR | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 1 | Prostacyclin Receptor Agonist [EPC] | 2 | 0.0001 |
| 2 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 3 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 2 | 0.0001 |
| 4 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 5 | Aromatic Amino Acid [EPC] | 3 | 0.0000 |
| 6 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 1 | 0.0000 |
| 7 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 9 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |